Detalhe da pesquisa
1.
IL-17A Orchestrates Reactive Oxygen Species/HIF1α-Mediated Metabolic Reprogramming in Psoriasis.
J Immunol
; 212(2): 302-316, 2024 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38019129
2.
A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy.
Expert Rev Proteomics
; 20(12): 381-395, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37970632
3.
Proteomic Investigation of COVID-19 Severity During the Tsunamic Second Wave in Mumbai.
Adv Exp Med Biol
; 1412: 175-195, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37378767
4.
Proteomics analysis of differentially abundant proteins in the rohu kidney infected with Edwardsiella tarda.
Comp Biochem Physiol Part D Genomics Proteomics
; 50: 101221, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38430708
5.
Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples.
STAR Protoc
; 3(1): 101177, 2022 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35233542
6.
Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue.
J Vis Exp
; (174)2021 08 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34515685
7.
Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors.
Front Oncol
; 11: 548243, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34055594
8.
Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19.
iScience
; 24(3): 102135, 2021 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33558857
9.
Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.
Front Physiol
; 12: 652799, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33995121